Clinical studies recruiting near Bayonne

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Centre Hospitalier de la Côte Basque · Pfizer · NCT07028853 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Centre Hospitalier de la Cote Basque ( Site 1315) · Merck Sharp & Dohme LLC · NCT06393374 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Ch de La Cote Basque · Hospices Civils de Lyon · NCT05444712 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · CH de la Côte Basque - Hôpital de Bayonne · The Lymphoma Academic Research Organisation · NCT06006117 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · Centre Hospitalier de la Côte Basque · Assistance Publique - Hôpitaux de Paris · NCT05387954 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Bayonne- Clinique Belharra · Federation Francophone de Cancerologie Digestive · NCT07270991 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · Centre Hospitalier de La Cote Basque · University Hospital, Lille · NCT05572229 Low Impact Laparoscopic in Colorectal Resection - PAROS2
NA · CH de la Côte Basque · University Hospital, Bordeaux · NCT04742881 Drowning-related Acute Respiratory Failure
NA · Centre Hospitalier de la Côte Basque - Urgences · Assistance Publique Hopitaux De Marseille · NCT06183827 Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · CHCB · UNICANCER · NCT07661927 Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Me
Phase N/A · Ch - Centre Hospitalier de La Côte Basque · Federation Francophone de Cancerologie Digestive · NCT06353854 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Centre Hospitalier de la Côte Basque · Bristol-Myers Squibb · NCT06561386 Autonomous Methadone Delivery System by Nurses
NA · CSAPA, Association Bizia, Centre Hospitalier de la Côte Basq · Hospices Civils de Lyon · NCT07085377 CARE1 Pragmatic Clinical Trial
Phase 3 · CH de la Côte Basque · Gustave Roussy, Cancer Campus, Grand Paris · NCT06364631 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f
Phase 3 · Bayonne- Clinique Belharra · Federation Francophone de Cancerologie Digestive · NCT06207981 Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metast
NA · Centre Hospitalier · Federation Francophone de Cancerologie Digestive · NCT07124858 A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Phase N/A · CH de la côte Basque · Centre Hospitalier de PAU · NCT03755726 PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (
NA · Centre D'Onco. & Radioth. De Haute Energie Du Pays Basque (U · European Organisation for Research and Treatment of Cancer - · NCT04790253 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Centre Hospitalier de La Cote Basque · Hoffmann-La Roche · NCT05894239 Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
Phase 1/Phase 2 · Centre Hospitalier de la Côte Basque · Groupe Francophone des Myelodysplasies · NCT05181735 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Centre Hospitalier de la Côte Basque ( Site 0633) · Merck Sharp & Dohme LLC · NCT06136624 Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced
Phase 2 · Centre Hospitalier de la Côte Basque · University Hospital, Clermont-Ferrand · NCT07205731 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3 · Clinique Belharra-Ramsay Sante · European Organisation for Research and Treatment of Cancer - · NCT05512364 Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syn
Phase N/A · Centre Hospitalier Côte Basque · Centre Hospitalier de la côte Basque · NCT07090460 Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamid
Phase 3 · CH Bayonne · Alianza multidisciplinar para la investigación de los tumore · NCT07333066 Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · Research Site · AstraZeneca · NCT06750289 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Centre Hospitalier de la Côte Basque · OSE Immunotherapeutics · NCT06472245 French Observatory of ElectroConvulsive Therapy (ECT)
Phase N/A · CH Cote Basque · Centre Hospitalier Henri Laborit · NCT04477434 Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar
Phase N/A · Chu de La Côte Basque · EG Labo · NCT07077681 Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
NA · Centre Hospitalier de la Côte Basque · Institut Bergonié · NCT02534649

Look up another city

Look up another condition